25.39
Anbio Biotechnology Borsa (NNNN) Ultime notizie
Head to Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
COREwafer Industries Inc. (OTCMKTS:AHIX) Short Interest Up 126.9% in January - Defense World
GRAIL (GRAL) Projected to Post Earnings on Thursday - Defense World
Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Critical Analysis: Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Anbio Biotechnology Class A Shares Took Off - TipRanks
Anbio Biotechnology Class A Shares Surge After Volatility Pause - TipRanks
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
InvestingPro’s overvalued warning saved investors from 54% Anbio Bio crash By Investing.com - Investing.com South Africa
Intel, Oracle among market cap stock movers on Monday By Investing.com - Investing.com Nigeria
Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair - TipRanks
Anbio Biotechnology Announces Board and Committee Changes, Effective January 21, 2026 - marketscreener.com
Anbio Biotechnology (NNNN) Stock Analysis: A Rollercoaster Year With Growth Potential - DirectorsTalk Interviews
Industries Limited Rebound Backed by Sentiment ShiftMACD Trading Signals & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com
S&P 500 Futures Up in Premarket Trading; QXO, Mosaic Lag - Barron's
Anbio Biotechnology falls -5.8% - MSN
Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - simplywall.st
Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance
Anbio Biotechnology Posts Higher Margins and Profits Despite Revenue Dip in First Half of 2025 - The Globe and Mail
Intel, Oracle among market cap stock movers on Monday - Investing.com
Anbio Biotechnology | 6-K: Report of foreign private issuer (related to financial reporting) - 富途牛牛
Anbio Biotechnology Reports Earnings Results for the Half Year Ended June 30, 2025 - marketscreener.com
Why Anbio Biotechnology Class A Shares Are Sliding - TipRanks
Coupang and Regencell among market cap stock movers on Friday By Investing.com - Investing.com India
Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks
Year-End Review | The 2025 US IPO Gainers List is Out! Anbio Biotechnology Soars Over 570%, 'First Stablecoin Stock' Circle Surges More Than 180% - 富途牛牛
Anbio Biotechnology rises 11.2% - MSN
Why Anbio Biotechnology Class A Shares Are Rising - TipRanks
Top US Stock Losers Today (December 10, 2025): Why Polestar, AeroVironment, Aegon and Other Names Are Sinking - ts2.tech
Biggest Stock Losers Today (December 5, 2025): Parsons, Adaptive Biotechnologies, SentinelOne, SoFi and More Slide Despite Calm Markets - TechStock²
Morning Market Movers: PLRZ, PMI, CBIO, HY See Big Swings - RTTNews
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Strong Buy Ratings Signal Potential 25.69% Upside - DirectorsTalk Interviews
Anbio Biotechnology (NNNN) Stock Analysis Report | Financials & Insights - Benzinga
Anbio Biotechnology plummets 56% after InvestingPro’s overvalued warning By Investing.com - Investing.com Nigeria
Anbio Biotechnology trading resumes - MSN
eToro adds 39 US stocks to lineup of investment instruments - FX News Group
Working capital per share of Anbio Biotechnology Class A – DUS:N3B - TradingView
Anbio Biotechnology rises 15.4% - MSN
Anbio Biotechnology Shares Surge Amid Auditor Appointment - TipRanks
Anbio BiotechnologyClass A Ordinary Shares (Nasdaq:NNNN) Stock Quote | Star Tribune - FinancialContent
Anbio Biotechnology Appoints New Auditor - TipRanks
Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility In The Healthcare Sector - DirectorsTalk Interviews
[6-K] Anbio Biotechnology Current Report (Foreign Issuer) | NNNN SEC FilingForm 6-K - Stock Titan
Anbio Biotechnology (N3B.F) latest press releases and corporate news - Yahoo Finance UK
Anbio Biotechnology trading halted, volatility trading pause - MSN
AMD, Palantir among market cap stock movers on Thursday By Investing.com - Investing.com Australia
Medtech test developer Anbio files for $9M US IPO - MSN
Why Anbio Biotechnology Class A Stocks Are Tumbling - TipRanks
AMD, Palantir among market cap stock movers on Thursday - Investing.com
Anbio Biotechnology Shares on a Wild Ride - TipRanks
Anbio Biotechnology falls -19.5% - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):